Andrew Hirsch - Sep 18, 2023 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
President & CEO, Director
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Sep 18, 2023
Transactions value $
$0
Form type
4
Date filed
9/19/2023, 07:24 PM
Previous filing
Aug 31, 2023
Next filing
Feb 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCCC Stock Option (Right to Buy) Award $0 +490K $0.00 490K Sep 18, 2023 Common Stock 490K $2.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full on September 18, 2025, subject to the Reporting Person's continued service on such date.